RPG Group company CESC Ltd has decided to spend Rs 2000 crore in 3-5 years for strengthening its distribution network.

Recently, the company has tied-up with Singapore-based SP Global Solution (SGPC) for technical assistance in revamping its distribution system.  

Under the arrangement, SPGC, a subsidiary of Singapore Power Group, will offer three-fold consultancy for a year, which will involve strategic planning, technology application and process standardization for the 567-km licensed area of CESC.  

Addiction of internet among youngsters has become a matter of concern for Chinese government. According to statistics, China has the world's largest online population at 253 million people. 

A top Chinese legislator said that about 10 percent of China's Web users under the age of 18, or four million people, were addicted to the Internet, mainly to "unhealthy" online games. 

35 fresh cases of dengue were reported in Ludhiana. These new cases revealed that despite the various steps taken by government authorities to prevent dengue, fresh cases of dengue are pouring in at various hospitals across the city everyday. 

The overall number of cases has touched the 3,500 mark with over 400 cases put in the suspected cases category and over 1,000 patients being treated at the hospitals in the city hailing from other parts of the state.

A recent study showed that regeneration of damaged nerves due to brain or spinal cord is possible by silencing natural growth inhibitors.

Researchers at the Children's Hospital Boston removed the two key inhibitory regulators of the mTOR pathway known as PTEN and TSC1. Found in the brain cells of mice, these regulators are known to be active in cells during growth and development, but eventually slow down in control once neurons have matured. 

Health officials gave oral polio vaccine (OPV) drops to 8.80 lakh children, out of approximately 13 lakh across the city who come under the BMC’s purview. These children were vaccinated through 6,800 booths in the city under polio immunisation programme on Sunday. Health officials said that the turnout was better than the previous drive in July which had reported a 65 % turnout. 

A study conducted by OSI Pharmaceuticals Inc. of Melville and its partners in an anti-lung cancer drug, Tarceva indicates that the medication slows the advance of lung cancer when it is administered after chemotherapy.

On the other hand, another study has found that a combination of Avastin and Tarceva were ineffective in prolonging the life of cancer patients. 

The results of the study by OSI executives will be submitted at an upcoming medical conference. Thereafter they would be submitted to the US FDA for approval of Tarveca.